Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

0.8955
+0.07789.51%
Post-market: 0.8559-0.0396-4.42%19:59 EDT
Volume:271.79K
Turnover:235.67K
Market Cap:111.74M
PE:-0.54
High:0.9126
Open:0.8270
Low:0.8270
Close:0.8177
Loading ...

Vor Biopharma Expects to Raise $55.6 Million From Private Placement; Shares Up

MT Newswires Live
·
27 Dec 2024

Vor Biopharma Secures $55.6M for Cancer Therapy Trials

TIPRANKS
·
27 Dec 2024

Vor Bio prices 55.87M shares at 99.425c in private placement

TIPRANKS
·
27 Dec 2024

Press Release: Vor Bio Announces $55.6 Million Private Placement

Dow Jones
·
27 Dec 2024

We're A Little Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate

Simply Wall St.
·
24 Dec 2024

Vor Biopharma Price Target Maintained With a $17.50/Share by HC Wainwright & Co.

Dow Jones
·
11 Dec 2024

Vor Bio trem-cel relapse-rate remains low, says Oppenheimer

TIPRANKS
·
10 Dec 2024

Vor Biopharma’s Strategic Advances and Promising Clinical Trial Results Justify Buy Rating

TIPRANKS
·
10 Dec 2024

Vor Bio announces updated data from Phase 1/2 VBP1-1 study

TIPRANKS
·
09 Dec 2024

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design

THOMSON REUTERS
·
09 Dec 2024

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

GlobeNewswire
·
09 Dec 2024

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)

TIPRANKS
·
25 Nov 2024

Vor Biopharma’s Trem-cel Therapy Shows Promise with Positive Patient Dosing and Upcoming Data Presentation

TIPRANKS
·
11 Nov 2024

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR) and Sight Sciences (SGHT)

TIPRANKS
·
08 Nov 2024

Vor Bio price target lowered to $14 from $22 at Baird

TIPRANKS
·
08 Nov 2024

Vor Biopharma Price Target Maintained With a $17.50/Share by HC Wainwright & Co.

Dow Jones
·
08 Nov 2024